Tonix Pharmaceuticals Highlights Therapeutic Programs on CEONEWS.Tv Equities.com Dr. Lederman's past accomplishments include the elucidation of the molecular basis of T cell helper function, which led to the development of therapeutic candidates for autoimmune diseases and organ transplant rejection in collaboration with Biogen ... |
